Abivax SA (ABVX)
NASDAQ: ABVX · IEX Real-Time Price · USD
12.36
-0.04 (-0.32%)
Jul 22, 2024, 10:29 AM EDT - Market open
Abivax Employees
Abivax had 61 employees as of December 31, 2023. The number of employees increased by 37 or 154.17% compared to the previous year.
Employees
61
Change (1Y)
37
Growth (1Y)
154.17%
Revenue / Employee
$84,171
Profits / Employee
-$2,691,075
Market Cap
779.23M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
Embecta | 2,200 |
Phibro Animal Health | 1,920 |
Atrion | 712 |
Aurinia Pharmaceuticals | 300 |
OrthoPediatrics | 247 |
Simulations Plus | 197 |
Olema Pharmaceuticals | 74 |
Immunome | 55 |
ABVX News
- 6 days ago - Abivax Provides Operational and Key Program Update - GlobeNewsWire
- 6 weeks ago - Abivax releases the results of its May 30, 2024 Ordinary and Extraordinary General Meeting - GlobeNewsWire
- 3 months ago - Abivax reports 2023 financial results and operational update - GlobeNewsWire
- 5 months ago - Abivax Announces Presentation of Four Abstracts for Obefazimod in Ulcerative Colitis and Sponsorship of Scientific Symposium at The 19th Congress of European Crohn's and Colitis Organization (ECCO) - Accesswire
- 9 months ago - Citi Appointed as Depositary Bank for Abivax SA's ADR Program - Business Wire
- 9 months ago - Abivax Announces Closing of its Initial Public Offering on the Nasdaq Global Market - Accesswire
- 9 months ago - Abivax Announces Trading Resumption of its Ordinary Shares on Euronext Paris - Accesswire
- 9 months ago - Abivax Announces the Pricing of its Initial Public Offering on the Nasdaq Global Market - Accesswire